6007 ORAL Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
Michel Seymour(University of Leeds), Philip Quirke(University of Leeds), Susan D. Richman(University of Leeds), G.W. Middleton, Vicky Napp(University of Leeds), Sarah Brown(University of Leeds), Mark Hill(Maidstone Hospital), C. Olivier, Tim Maughan(University of Liverpool), N. Maisey(Guy's Hospital)
Cited by 7
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
|Journal of Clinical Oncology|2011|678